Clinical Trial Update: Immune Tolerance Study With Aldurazyme® (Laronidase) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 1/Phase 2 immune tolerance study of Aldurazyme (Laronidase) in patients with mucopolysaccharidosis I. The study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis

Drugs mentioned

• Aldurazyme (Laronidase)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Mucopolysaccharidosis I | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-07-02